Even when AI designs molecules with potential as medicines, drug development can be delayed if the process of producing them ...

AI drug discovery is changing biotechnology by analyzing biological data, identifying candidates and improving clinical trial ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Joining me now is Dr. Andrew Snyder. He’s a drug researcher and developer and scientist, and for full disclosure, he’s also my brother. Dr. Snyder, Andy, good to see you this morning. Maybe ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. Researchers have applied ...

OpenAI has acquired Orchestra Bio, a platform that helps pharmaceutical and biotechnology companies coordinate complex drug ...

OpenAI has acquired Orchestra Bio, a drug development coordination platform. The acquisition aims to merge Orchestra Bio with ...

Some drugs may seem like they were named by throwing darts at the alphabet – but the process of drug naming is actually very intentional. In an interview with Fox News Digital, Dr. Dave Latshaw, CEO ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

Detailed analyses of ligand choice, linkage vector and linker length enabled the development of bitopic inhibitors of ABL1 and EGFR kinases, including an ABL1 inhibitor with enhanced activity against ...